AI assistant
PROCEPT BioRobotics Corp — Director's Dealing 2022
Dec 20, 2022
31665_dirs_2022-12-20_c2fd01d4-b125-4bc3-8612-b825063cbb87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2022-12-16
Reporting Person: Nouri Alaleh (EVP, CLO, CORP. SEC.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-16 | Common Stock | S | 20000 | $41.9674 | Disposed | 27126 | Direct |
| 2022-12-19 | Common Stock | S | 8511 | $43.4341 | Disposed | 18615 | Direct |
| 2022-12-19 | Common Stock | S | 11489 | $43.0783 | Disposed | 7126 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2022.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.31 to $41.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3: Includes 658 shares acquired on September 14, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.66 to $43.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.30 to $42.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.